Bay Street News, 2020

HOUSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) — Apache Corporation (NASDAQ: APA) today announced the commencement of tender offers (each, an […]

PARSIPPANY, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its […]

NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and […]

HOUSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) — RigNet, Inc. (NASDAQ: RNET) today announced that it will release its second quarter […]

SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the […]

CORAL GABLES, Fla., Aug. 03, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]

HAMPTON, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) will report second quarter 2020 financial results on […]

CAMBRIDGE, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing […]

— Appointed David Meeker, M.D., as President and Chief Executive Officer –— FDA granted rare pediatric disease designations for setmelanotide […]

DALLAS and FORT WORTH, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company […]